Immune alterations in malignant melanoma and current immunotherapy concepts

Author： Shimanovsky Alexei   Jethava Ashif   Dasanu Constantin A  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.10, 2013-10, pp. : 1413-1427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy of melanoma: a critical review of current concepts and future strategies

By Riker Adam I   Radfar Soroosh   Liu SuHu   Wang Yixiang   Khong Hung T  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 345-358

Informa Healthcare

Access to resources Recommend Favorite

Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression

By Kretz-Rommel Anke   Bowdish Katherine S  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 5-15

Informa Healthcare

Access to resources Recommend Favorite

Current status of adoptive immunotherapy of malignancies

By Morse Michael A   Clay Timothy M   Lyerly H Kim  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 237-247

Informa Healthcare

Access to resources Recommend Favorite

The role of biological response modifiers in malignant melanoma

By Lens Marko B  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 8, 2003-12 ,pp. : 1225-1231

Informa Healthcare

Access to resources Recommend Favorite